These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31718300)

  • 41. Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep.
    Debbarh HS; Zygmunt MS; Dubray G; Cloeckaert A
    Vet Microbiol; 1996 Dec; 53(3-4):325-37. PubMed ID: 9008343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel recombinant multi-epitope protein against Brucella melitensis infection.
    Yin D; Li L; Song D; Liu Y; Ju W; Song X; Wang J; Pang B; Xu K; Li J
    Immunol Lett; 2016 Jul; 175():1-7. PubMed ID: 27133932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenic properties of Brucella melitensis cell-wall fractions in BALB/c mice.
    Cloeckaert A; Jacques I; Limet JN; Dubray G
    J Med Microbiol; 1995 Mar; 42(3):200-8. PubMed ID: 7884802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein.
    Al-Mariri A
    Vaccine; 2010 Feb; 28(7):1766-70. PubMed ID: 20036752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The SARS-CoV-2 rS1-E-PLGA nanovaccine and evaluation of its immune effect in BALB/c mice.
    Huang J; Ding Y; Yao J; Peng K; Deng K; Zhang M; Zhang Y; Zuo J
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5255-5263. PubMed ID: 35916825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.
    Lecaroz MC; Blanco-Prieto MJ; Campanero MA; Salman H; Gamazo C
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1185-90. PubMed ID: 17220415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A; Mahmoud NH; Hammoud R
    Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved performance of Brucella melitensis native hapten over Brucella abortus OPS tracer on goat antibody detection by the fluorescence polarization assay.
    Ramírez-Pfeiffer C; Díaz-Aparicio E; Rodríguez-Padilla C; Morales-Loredo A; Alvarez-Ojeda G; Gomez-Flores R
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):223-9. PubMed ID: 18359093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate.
    Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T
    APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
    Yang X; Walters N; Robison A; Trunkle T; Pascual DW
    Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2015 Oct; 33(42):5532-5538. PubMed ID: 26384448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of homologous antigen in the serological diagnosis of brucellosis caused by Brucella melitensis.
    Tittarelli M; Giovannini A; Conte A; Di Ventura M; Nannini D; Caporale V
    J Vet Med B Infect Dis Vet Public Health; 2005 Mar; 52(2):75-81. PubMed ID: 15752266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
    Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
    Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice.
    Guilloteau LA; Laroucau K; Vizcaíno N; Jacques I; Dubray G
    Vaccine; 1999 Jan; 17(4):353-61. PubMed ID: 9987174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.
    Imbuluzqueta E; Gamazo C; Lana H; Campanero MÁ; Salas D; Gil AG; Elizondo E; Ventosa N; Veciana J; Blanco-Prieto MJ
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3326-33. PubMed ID: 23650167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.